Skip to main content
. 2020 Apr 1;13:196. doi: 10.1186/s13104-020-05040-2

Table 2.

Comparison between patients with MACE, patients without MACE regarding echocardiography or tissue Doppler parameters

Patients with MACE [n = 106, (39.8%)] Patients without MACE [n = 160, (60.2%)] (P value)*
Mean (SD) Mean (SD)
RVBD 3.42 (0.47) 3.41 (0.44) 0.88
RVLD 7.82 (0.23) 7.82 (0.23) 0.89
WMSI 7.16 (3.18) 6.68 (2.64) 0.19
Mitral E/A ratio 0.98 (0.34) 1.02 (0.35) 0.49
Mitral E/e′ ratio 11.32 (4.23) 11.28 (3.18) 0.92
LVEF% 38.03 (2.95) 40.09 (3.68) 0.001*
LAVI 28.11 (2.02) 27.64 (1.73) 0.042*
Tricuspid E/A ratio 1.07 (0.34) 1.05 (0.36) 0.67
Tricuspid E/e′ ratio 6.73 (2.45) 6.44 (1.95) 0.29
S’ wave PTSV (cm/s) 10.18 (1.79) 11.39 (2.17) 0.001*
TAPSE 1.52 (0.13) 1.70 (0.17) 0.001*
RVFAC% 36.41 (2.17) 39.27 (2.97) 0.001*
LV ESd (mm) 29.56 (2.27) 29.03 (2.20) 0.06
LV EDd (mm) 48.58 (2.05) 48.65 (2.08) 0.79
LV EDV (ml) 147.29 (12.44) 144.43 (11.86) 0.06
LV ESV (ml) 46.66 (6.34) 44.57 (6.33) 0.009*

Patients with MACE: Patients who have experienced MACE events within 30-days period after AMI. Patients without MACE: Patients who have not experience events in whole 30-days period post AMI. LVEF%: left ventricular ejection fraction; LAVI: left atrial volume index; RVFAC: right ventricular fractional area change; LV ESd: left ventricular end-systolic diameter; LV EDd left ventricular end-diastolic diameter; LV EDV (left ventricular end-diastolic volume, LV ESV: left ventricular end-systolic volume. RVLD: RV longitudinal diameter; RVBD: Rt ventricular basal diameter; S’ wave PTSV: S’ wave peak tricuspid systolic velocity; TAPSE: tricuspid annular plane systolic excursion; WMSI: wall motion score index

* p value < 0.05